Amyloid β peptide adversely affects spine number and motility in hippocampal neurons

Molecular and Cellular Neuroscience

Volumn 33, Issue 3, 2006, Pages 274-282

  Shrestha, Brikha R ^a   Vitolo, Ottavio V ^b   Joshi, Powrnima ^a   Lordkipanidze, Tamar ^a   Shelanski, Michael ^b   Dunaevsky, Anna ^a  

^a BROWN UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIC AMP; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL COUNT; CELL DENSITY; CELL MATURATION; CELL MOTILITY; CELL STRUCTURE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; DOWN SYNDROME; HIPPOCAMPUS; IMAGING; MOUSE; NEWBORN; NONHUMAN; PHOTON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL MOVEMENT; CELL SURVIVAL; CYCLIC AMP; DENDRITIC SPINES; DIAGNOSTIC IMAGING; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; MICE; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; PHOSPHODIESTERASE INHIBITORS; PYRAMIDAL CELLS; ROLIPRAM; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRANSFECTION;

EID: 33750711451     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2006.07.011     Document Type: Article

References (61)

1. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., and Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20 (2005) 187-198
2. Bach M.E., Barad M., Son H., Zhuo M., Lu Y.F., Shih R., Mansuy I., Hawkins R.D., and Kandel E.R. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5280-5285
3. Barad M., Bourtchouladze R., Winder D.G., Golan H., and Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15020-15025
4. Barbiero L., Benussi L., Ghidoni R., Alberici A., Russo C., Schettini G., Pagano S.F., Parati E.A., Mazzoli F., Nicosia F., Signorini S., Feudatari E., and Binetti G. BACE-2 is overexpressed in Down's syndrome. Exp. Neurol. 182 (2003) 335-345
5. Belichenko P.V., Masliah E., Kleschevnikov A.M., Villar A.J., Epstein C.J., Salehi A., and Mobley W.C. Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome. J. Comp. Neurol. 480 (2004) 281-298
6. Bloodgood B.L., and Sabatini B.L. Neuronal activity regulates diffusion across the neck of dendritic spines. Science 310 (2005) 866-869
7. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., and Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2 (1999) 271-276
8. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
9. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
10. Dailey M.E., and Smith S.J. The dynamics of dendritic structure in developing hippocampal slices. J. Neurosci. 16 (1996) 2983-2994
11. Deng J., and Dunaevsky A. Dynamics of dendritic spines and their afferent terminals: spines are more motile than presynaptic boutons. Dev. Biol. 277 (2005) 366-377
12. Dunaevsky A., and Mason C.A. Spine motility: A means towards an end?. Trends Neurosci. 26 (2003) 155-160
13. Dunaevsky A., Tashiro A., Majewska A., Mason C., and Yuste R. Developmental regulation of spine motility in the mammalian central nervous system. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13438-13443
14. Dunaevsky A., Blazeski R., Yuste R., and Mason C. Spine motility with synaptic contact. Nat. Neurosci. 4 (2001) 685-686
15. Engert F., and Bonhoeffer T. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399 (1999) 66-70
16. Fiala J.C., Spacek J., and Harris K.M. Dendritic spine pathology: Cause or consequence of neurological disorders?. Brain Res. Brain Res. Rev. 39 (2002) 29-54
17. Fischer M., Kaech S., Knutti D., and Matus A. Rapid actin-based plasticity in dendritic spines. Neuron 20 (1998) 847-854
18. Fischer M., Kaech S., Wagner U., Brinkhaus H., and Matus A. Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat. Neurosci. 3 (2000) 887-894
19. Freir D.B., Holscher C., and Herron C.E. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85 (2001) 708-713
20. Gong, B., Vitolo, O.V., Trinchese, F., Liu, S., Shelanski, M., and Arancio, O. 2004. Acute and persistent improvement in LTP and memory deficits in a mouse model of Alzheimer's disease following treatment with rolipram. J. Clin. Invest. 114, 1624--1634.
21. Gray E.G. Axo-somatic and axo-dendritic synapses of the cerebral cortex: An electron microscopic study. J. Anat. 83 (1959) 420-433
22. Hamaguchi T., Ono K., and Yamada M. Anti-amyloidogenic therapies: Strategies for prevention and treatment of Alzheimer's disease. Cell Mol. Life Sci. (2006)
23. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., and Selkoe D.J. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19 (1999) 8876-8884
24. Hartman R.E., Izumi Y., Bales K.R., Paul S.M., Wozniak D.F., and Holtzman D.M. Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease. J. Neurosci. 25 (2005) 6213-6220
25. Head E., and Lott I.T. Down syndrome and beta-amyloid deposition. Curr. Opin. Neurol. 17 (2004) 95-100
26. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., and Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3228-3233
27. Isacson O., Seo H., Lin L., Albeck D., and Granholm A.C. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci. 25 (2002) 79-84
28. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., and Malinow R. APP processing and synaptic function. Neuron 37 (2003) 925-937
29. Kasai H., Matsuzaki M., Noguchi J., Yasumatsu N., and Nakahara H. Structure-stability-function relationships of dendritic spines. Trends Neurosci. 26 (2003) 360-368
30. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24 (2004) 10191-10200
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
32. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6448-6453
33. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
34. Majewska A., and Sur M. Motility of dendritic spines in visual cortex in vivo: changes during the critical period and effects of visual deprivation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 16024-16029
35. Majewska A., Tashiro A., and Yuste R. Regulation of spine calcium compartmentalization by rapid spine motility. J. Neurosci. 20 (2000) 8262-8268
36. Maletic-Savatic M., Malinow R., and Svoboda K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 283 (1999) 1923-1927
37. Marin-Padilla M. Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study. Brain Res. 44 (1972) 625-629
38. Matsuzaki M., Honkura N., Ellis-Davies G.C., and Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature 429 (2004) 761-766
39. Moolman D.L., Vitolo O.V., Vonsattel J.P., and Shelanski M.L. Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol. 33 (2004) 377-387
40. Murphy D., and Segal M. Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1482-1487
41. Navakkode S., Sajikumar S., and Frey J.U. The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging. J. Neurosci. 24 (2004) 7740-7744
42. Nimchinsky E.A., Sabatini B.L., and Svoboda K. Structure and function of dendritic spines. Annu. Rev. Physiol. 64 (2002) 313-353
43. Noguchi J., Matsuzaki M., Ellis-Davies G.C., and Kasai H. Spine-neck geometry determines NMDA receptor-dependent Ca2+ signaling in dendrites. Neuron 46 (2005) 609-622
44. Purpura D. Dendritic spine "dysgenesis" and mental retardation. Science 186 (1974) 1126-1128
45. Roselli F., Tirard M., Lu J., Hutzler P., Lamberti P., Livrea P., Morabito M., and Almeida O.F. Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J. Neurosci. 25 (2005) 11061-11070
46. Rowan M.J., Klyubin I., Cullen W.K., and Anwyl R. Synaptic plasticity in animal models of early Alzheimer's disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358 (2003) 821-828
47. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., and Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320 (1989) 1446-1452
48. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
49. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 (2005) 1051-1058
50. Teller J.K., Russo C., DeBusk L.M., Angelini G., Zaccheo D., Dagna-Bricarelli F., Scartezzini P., Bertolini S., Mann D.M., Tabaton M., and Gambetti P. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2 (1996) 93-95
51. Trachtenberg J.T., Chen B.E., Knott G.W., Feng G., Sanes J.R., Welker E., and Svoboda K. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420 (2002) 788-794
52. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7 (2004) 1181-1183
53. Tsay D., and Yuste R. On the electrical function of dendritic spines. Trends Neurosci. 27 (2004) 77-83
54. Turrigiano G.G., Leslie K.R., Desai N.S., Rutherford L.C., and Nelson S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391 (1998) 892-896
55. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., and Shelanski M. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13217-13221
56. Wallace W., and Bear M.F. A morphological correlate of synaptic scaling in visual cortex. J. Neurosci. 24 (2004) 6928-6938
57. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., and Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924 (2002) 133-140
58. Wisniewski K.E., Wisniewski H.M., and Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17 (1985) 278-282
59. Yuste R., Majewska A., and Holthoff K. From form to function: Calcium compartmentalization in dendritic spines. Nat. Neurosci. 3 (2000) 653-659
60. Zito K., Knott G., Sheperd, G.M., Shenolikar S., and Svoboda K. Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton. Neuron 43 (2004) 321-334
61. Ziv N.E., and Smith S.J. Evidence for a role of dendritic filopodia in synaptogenesis and spine formation. Neuron 17 (1996) 91-102